News & Updates

Daunorubicin for newly diagnosed AML: Does more equate to better outcomes?

In acute myeloid leukaemia (AML) patients who received the 7+3* induction, a higher daunorubicin dose or a double induction did not seem to yield better outcomes, findings from the two-part phase III SAL Dauno-Double trial suggest.

RAS inhibitor discontinuation of no help in slowing kidney decline

Stopping treatment with renin–angiotensin system (RAS) inhibitors in patients with advanced chronic kidney disease does not appear to raise the levels of estimated glomerular filtration rate (eGFR) or decelerate its decline, according to a study.

Heavy coffee drinking poses CVD mortality risk in presence of severe hypertension

Individuals with severe hypertension may do well to refrain from drinking too much coffee, as it contributes to an increased risk of cardiovascular disease (CVD) death, a study has found.

TACE + apatinib: A potential new strategy for intermediate/advanced HCC?

Put Life Back in Your Patients’ Hands: Winning the fight Against Peripheral Neuropathy in Diabetic Patients

Dear Doctor,  

In celebration of World Diabetes Day, P&G Health Philippines, in partnership with the Philippine Association of Family Physicians (PAFP), Philippine Society of Endocrinology, Diabetes and Metabolism (PSEDM), and the Cavite Medical Society (CMS) recently held the “Put Life Back in Your Patients’ Hands: Winning the Fight against Neuropathy in Diabetes” physical-digital event for healthcare professionals, we made sure you don’t miss the updates and innovations in nerve care that were discussed. 

Catch the highlights of the “phygital” event here.  

Minimally invasive cardiac surgery more beneficial than median sternotomy in Asians

A minimally invasive cardiac surgery (MICS) is both safe and effective in a carefully selected group of cardiac patients in Singapore, producing better outcomes when compared with conventional median sternotomy (MS), according to a study.